Description
Keytruda (pembrolizumab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.https://www.drugs.com/keytruda.html
$19.99
This report includes data from the FDA’s Adverse Events Reports for 2018. We removed reports where the subject of the report was taking only this drug. This report provides the following fields:
Keytruda (pembrolizumab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.https://www.drugs.com/keytruda.html